Wednesday, April 29, 2020

Glenmark Pharma to conduct trials for potential COVID-19 drug, shares jump

Glenmark Pharma to conduct trials for potential COVID-19 drug, shares jump Favipiravir, manufactured under the brand name Avigan by a unit of Japan#39;s Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

from Moneycontrol Business News https://ift.tt/3bQ2Kd5

No comments:

Post a Comment

US equities end lower as valuation concerns creep in

U.S. stocks closed lower on Wednesday as investors took profits amid concerns about high valuations flagged by Fed Chair Powell. The market ...